Summary
Pfizer Inc. (PFE) announced a key change in its accounting leadership within an 8-K filing dated March 2, 2020. The company reported the retirement of Loretta V. Cangialosi, who served as Senior Vice President - Controller and Principal Accounting Officer. This transition marks the end of Ms. Cangialosi's tenure, effective March 1, 2020. Taking over the critical role of Principal Accounting Officer and Senior Vice President - Controller is Jennifer B. Damico. Ms. Damico brings extensive experience, having been with Pfizer since 1992 and holding various leadership positions within Audit and Finance, most recently as Senior Vice President - Corporate Audit. Additionally, Gordon Loh has been appointed Senior Vice President, Corporate Audit, further strengthening the company's audit function. These appointments reflect Pfizer's commitment to maintaining robust financial oversight and leadership continuity.
Key Highlights
- 1Loretta V. Cangialosi, Senior Vice President - Controller and Principal Accounting Officer, is retiring effective March 1, 2020.
- 2Jennifer B. Damico has been elected as the new Senior Vice President - Controller and Principal Accounting Officer, effective March 1, 2020.
- 3Ms. Damico has a long tenure at Pfizer (since 1992) with significant experience in Audit and Finance roles.
- 4Ms. Damico's most recent role was Senior Vice President - Corporate Audit.
- 5Gordon Loh has been appointed Senior Vice President, Corporate Audit, effective March 1, 2020.
- 6Mr. Loh has 25 years of experience at Pfizer and previously held the position of Vice President of Finance for Pfizer Global Supply.
- 7These appointments are effective at the beginning of March 2020, indicating a smooth leadership transition.